Avita Therapeutics Inc
Cerrado
9.77 -3.36
Resumen
Variación precio
24h
Mínimo
10.05
Máximo
10.36
Ingresos | 2.9M -7.7M |
|---|---|
Ventas | 2.5M 22M |
BPA | -0.25 |
Margen de beneficios | -35.31 |
Empleados | 226 |
EBITDA | 3.8M -4.8M |
Próximas Ganancias | 5 nov 2026 |
|---|
Capitalización Mercado | 204M 346M |
|---|---|
Apertura anterior | 13.13 |
Cierre anterior | 9.77 |
Avita Therapeutics Inc Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Avita Therapeutics Inc previsión
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Avita Therapeutics Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.